Healthy Clinical Trial
Official title:
Overnight Weight Loss, Sleep Structure and the Endocrine System
The objectives of the present study are:
1. to evaluate if overnight weight loss is dependent on sleep structure assessed by
polysomnography;
2. to compare weight loss rate during sleep and awake rest;
3. to compare night weight loss profile of normal and obese volunteers.
Weight loss can be caused by loss of body mass due to metabolism and by water loss as
insensible water loss, sweating, or excretion in feces and urine. Eighty-three percent of
the total weight loss is due to insensible water loss from airways and skin. Water loss rate
varies according to changes in activity and ambient temperature and humidity. Although
weight loss during sleep is a well-known phenomenon, there are no studies relating it to
sleep structure or any other functions during the distinct sleep stages, particularly SWS
and REM sleep. There is evidence suggesting a homeostatic mechanism for weight control in
animal models and humans. This mechanism is thought to be dependent on energy intake, energy
expenditure, and environmental conditions. The literature suggests that sleep is important
for weight homeostasis on a long term since sleep shortage is associated with overweight
status, but overnight weight variation had not yet been studied. Considering these facts, we
hypothesized that the overnight weight loss rate is not uniform throughout the sleep period.
We also intend to compare weight loss rate during sleep and awake rest.
Intervention: Normal and obese volunteers will undergo whole night polysomnography with
continuous body weight and temperature register after an adaptation night. After that,
volunteers will remain awake resting in bed during the following day for continuous weight
and temperature register.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |